Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Differential expression of miRNAs in plasma exosomes between ESCC patients with lymph node metastasis(LNM+) and those without lymph node metastasis(LNM-)

ABSTRACT: Differential expression of miRNAs in plasma exosomes between ESCC patients with lymph node metastasis(LNM+) and those without lymph node metastasis(LNM-)

PROVIDER: PRJNA884661 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21722644.fastq.gz	Fastqsanger.gz
	SRR21722645.fastq.gz	Fastqsanger.gz
	SRR21722646.fastq.gz	Fastqsanger.gz
	SRR21722647.fastq.gz	Fastqsanger.gz
	SRR21722648.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

systematic proteomic of 20 cases of primary ESCC tumor tissue (T), matched normal tissue (N) and lymph node metastatic tissue (LN)

Project description:To obtain the global landscape of Khib in ESCC metastasis, 20 cases of primary ESCC tumor tissue (T), matched normal tissue (N) and lymph node metastatic tissue (LN) were subjected to systematic proteomic.

2026-06-29 | PXD037295 | Pride

Quantitative Khib proteomic analyses of 20 cases of primary ESCC tumor tissue (T), matched normal tissue (N) and lymph node metastatic tissue (LN)

2026-06-29 | PXD038252 | Pride

Differential expression of miRNAs in plasma exosomes between ESCC patients with lymph node metastasis(LNM+) and those without lymph node metastasis(LNM-)

Project description:To identify the candidate exosomal miRNAs involved in ESCC metastasis, we conducted small RNA sequencing to determine the miRNA expression profiles of plasma exosomes from 5 LNM+ and 5 LNM- ESCC patients

2022-10-02 | GSE214259 | GEO

Analysis of serum exosomal miRNAs associated with lymph node metastasis in esophageal squamous cell carcinoma

Project description:Preoperative prediction of lymph node (LN) metastasis is accepted as an important independent risk factor for treatment decision-making for esophageal squamous cell carcinoma (ESCC) patients. This study aimed to develop a non-invasive biomarker to identify LN metastasis preoperatively in ESCC patients with serum exosomal RNA-seq.

2020-07-30 | GSE155360 | GEO

SDR9C7 Promotes Lymph Node Metastases in Patients with Esophageal Squamous Cell Carcinoma

Project description:To identify the lymph node (LN) metastasis-associated genes in primary ESCC tumors, gene expression proﬁling assay (GEP) was performed to identify the differences in gene expression profiles between primary ESCC tumors that were with LN metastases (N+) and those without LN metastases (N-).

2018-08-14 | GSE118493 | GEO

Profiling circular RNA in esophageal squamous cell carcinoma (ESCC) with lymph node metastasis

Project description:Profiling circular RNA in esophageal squamous cell carcinoma (ESCC) with lymph node metastasis

| PRJNA632541 | ENA

Tumor Cell JAGGED-1 Promotes Lymph Node Metastasis and Predicts Recurrence in Lymph Node Positive Breast Cancer Patients [hdLEC_JAG1_TLA]

Project description:Purpose: Lymph node invasion is a hallmark of breast cancer disease progression, but current treatment strategies lack guidance from lymph node biomarkers. We investigated JAGGED1 (JAG1) as a promoter of lymph node metastasis and a prognostic biomarker in metastatic lymph node specimens. Experimental Design: We used mouse models to assess the role of JAG1 expression in human and mouse breast cancer cells on lymphovascular invasion, lymph node metastatic potential, transcriptional profiles, and tumor interactions with lymphatic endothelium. We examined breast and lymph node samples from 284 breast cancer patients to determine the correlative and prognostic value of tumoral JAG1 expression in the lymph node. Results: In matched human breast tumor and lymph node samples, tumor cells that invaded lymph nodes showed higher JAG1 expression than their associated primary tumors (P value < 0.0001). In multiple models, breast cancer cells with high JAG1 expression showed increased lymphovascular invasion, lymph node metastasis, lymph node metastatic outgrowth, and migration through lymphatic endothelium. Transcriptomic analysis indicated that tumoral JAG1 regulates both juxtacrine and paracrine signaling pathways that induce inflammatory and pro-metastatic genes in lymphatic endothelium. When examining patients with identical surgical treatments, patients with lymph node JAG1 H-scorelow showed increased 5-year recurrence free survival rates than patients with lymph node JAG1 H-scorehi (87% vs 70%, P=0.016). Conclusions: JAG1 expression promotes lymphovascular invasion and lymph node metastasis in murine models. In patients, high expression of JAG1 in tumor cells in lymph node metastases predicts reduced recurrence free survival.

2026-07-27 | GSE252953 | GEO

Tumor Cell JAGGED-1 Promotes Lymph Node Metastasis and Predicts Recurrence in Lymph Node Positive Breast Cancer Patients [MDA231LN_JAG1_KO1cnt_KO1rescue]

2026-07-27 | GSE252952 | GEO

Tumor Cell JAGGED-1 Promotes Lymph Node Metastasis and Predicts Recurrence in Lymph Node Positive Breast Cancer Patients [MDA231LN_JAG1_KO1_KO2]

2026-07-27 | GSE252950 | GEO

Tumor Cell JAGGED-1 Promotes Lymph Node Metastasis and Predicts Recurrence in Lymph Node Positive Breast Cancer Patients [MDA231-P_MDA231-LN]

2026-07-27 | GSE253035 | GEO